Protective effect of melatonin on zymosan-induced cellular damage

NeuroSignals

Volumn 8, Issue 1-2, 1999, Pages 136-142

  Cuzzocrea, Salvatore ^a   Caputi, Achille P ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Hydroxyl radical; Melatonin; Nonseptic shock; PARS; Peroxynitrite; Zymosan

Indexed keywords

FLUORESCENT DYE; HYDROXYL RADICAL; MELATONIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEROXYNITRITE; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DAMAGE; CELL PROTECTION; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; INTRAPERITONEAL DRUG ADMINISTRATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATION; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; RAT; SHOCK;

ANIMALS; ANTIOXIDANTS; DNA DAMAGE; INFLAMMATION; MACROPHAGES, PERITONEAL; MELATONIN; NAD; NITRATES; POLY(ADP-RIBOSE) POLYMERASES; RATS; SHOCK; ZYMOSAN;

EID: 0032996057     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000014582     Document Type: Article

References (37)

1. Goris RJA, Van Bebber IPT, Mollen RMH, Koopman JP: Does selective decontamination of the gastrointestinal tract prevent multiple organ failure? Arch Surg 1991; 126:561-565.
2. von Asmuth EJU, Maessen IG, Van Der Linden CJ, Buurman WA: Tumor necrosis factor alpha (TNFa) and interleukin 6 in zymosan-induced shock model. Scand J Immunol 1990;32:313-319.
3. Damas J, Remacle-Volon G, Bourdon V: Platelet-activating factor and vascular effects of zymosan in rats. Eur J Pharmacol 1993;231:231-236.
4. Rao TS, Currie JL, Shaffer AF, Isak-son PC: In vivo characterization of zymosan-induced mouse peritoneal inflammation. J Pharmacol Exp Ther 1993;269:917-925.
5. Cuzzocrea S, Zingarelli B, Sautebin L, Rizzo A, Crisafulli C, Campo GM, Costantino G, Calapai G, Nava F, Di Rosa M, Caputi AP: Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide. Shock 1997; 4:268-275.
6. Mainous MR, Ertel W, Chaudry IH, Deitch EA: The gut: A cytokine-generating organ in systemic inflammation? Shock 1995;4:193-199.
7. Cuzzocrea S, Filippelli A, Zingarelli, B, Falciani M, Caputi AP, Rossi F: Role of nitric oxide in a non-septic shock model induced by zymosan in the rat. Shock 1997;7:351-358.
8. Reiter RJ: Pineal melatonin: Cell biology of its synthesis and of its physiological interaction. Endocr Rev 1991;12:151-156.
9. Menendez-Pelaez A, Poeggeler B, Reiter RJ, Barlow-Walden LR, Pablos MI, Tan DX: Nuclear localization of melatonin in different mammalian tissues: Immunocytochemi-cal and radioimmunoassay evidence. J Cell Biochem 1994;53:373-382.
10. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ: Melatonin: A potent endogenous hydroxyl radical scavenger. Endocr J 1993; 1:57-62.
11. Reiter RJ: The role of the neurohormone melatonin as a buffer against macromolecular oxidative damage. Neurochem Int 1995;27:453-460.
12. Reiter RJ, Melchiorri D, Sewerynek E, Poeggeler B, Barlow-Walden L, Chuang J, Ortiz GG, Acuna-Castro-viejo D: A review of the evidence supporting melatonin’s role as an antioxidant. J Pineal Res 1995;18: 1-11.
13. Marshall KA, Reiter RJ, Poeggeler B, Aruoma OI, Halliwell B: Evaluation of the antioxidant activity of melatonin in vitro. Free Radic Biol Med 1996;21:307-315.
14. Sewerynek E, Abe M, Reiter RJ, Barlow-Walden LR, Chen L, Mccabe TJ, Roman LJ, Diaz-Lopez B: Melatonin administration prevents lipopolysaccharide-induced oxidative damage in phenobarbital-treated animals. J Cell Biochem 1995;58:436-444.
15. Melchiorri G, Reiter RJ, Attia AM, Hara M, Burgos A, Nistico G: Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci 1994; 56:83-89.
16. Daniels WMU, Reiter RJ, Mel-chiorri D, Sewerynek E, Plablos MI, Ortiz GG: Melatonin counteracts lipid peroxidation induced by carbon tetrachloride but does not restore glucose-6-phosphatase activity. J Pineal Res 1996;19:1-6.
17. Gilad E, Cuzzocrea S, Zingarelli B, Salzman AL, Szabo C: Melatonin is a scavenger of peroxinitrite. Life Sci 1997;60:PL169-174.
18. Pozo D, Reiter RJ, Calvo JR, Guerrero JM: Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci 1994;55:PL455-460.
19. Cuzzocrea S, Zingarelli B, Gilard E, Hake P, Salzman AL, Szabo C: Protective effect of melatonin in carrageenan-induced models of local inflammation. J Pineal Res 1997;3: 106-116.
20. Zingarelli B, O’Connor M, Wong H, Salzman AL, Szabo C: Peroxyni-trite-mediated DNA strand breakage activates poly-ADP ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccha-ride. J Immunol 1996; 156:350-358.
21. Darley-Usmar V, Halliwell B: Blood radicals. Reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm Res 1996;13:649-651.
22. Schraufstatter IU, Hinshaw DB, Hyslop PA, Spragg RG, Cochrane CG: Oxidant injury of cells: DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. J Clin Invest 1986;77:1312-1315.
23. Van Bebber IP, Lieners CFJ, Kolde-wijn EL, Redl H, Goris RJA: Superoxide dismutase and catalase in a experimental model of multiple organ failure. J Surg Res 1992;52:265-270.
24. Nieuwenhuijzen GAP, Haskel Y, Lu Q, Berg RD, Van Rooijen N, Goris RJ, Deitch EA: Macrophage elimination increases bacterial translocation and gut-origin septicaemia, but attenuates symptoms and mortality rate in a model of systemic inflammation. Ann Surg 1993;218:791-799.
25. Shayevitz JR, Miller C, Johnson KJ, Rodriguez JL: Multiple organ dysfunction syndrome: End organ and systemic inflammatory response in a mouse model of nonseptic origin. Shock 1995;4:389-396.
26. Cuzzocrea S, Zingarelli B, O’Connor M, Salzman AL, Caputi AP, Szabo C: Role or peroxynitrite and activation of poly (ADP ribose) synthetase in the vascular failure induced by zymosan-activated plasma. Br J Pharmacol 1997; 122:493-503.
27. Salvemini D, Wang ZQ, Wyatt P, Bourdon DM, Marino MH, Manning PR, Currie MG: Nitric oxide: A key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br J Pharmacol 1996;118:829-838.
28. Da Motta JL, Cunha FQ, Vargaftig BB, Ferreira SH: Drug modulation of antigen-induced paw oedema in guinea-pigs: Effects of lipopolysac-charide, tumour necrosis factor and leucocyte depletion. Br J Pharmacol 1994:112:111-116a.
29. Fernandez PM, Hensen A, Otani A, Hugli TE: Chemotactic response to human C3a and C5a anaphylatoxins: Evaluation of C3a and C5a leuko-taxis in vitro and under stimulated in vivo condition. J Immunol 1978; 120:109-115.
30. Mehta JL, Lawson DL, Nicolini FA, Ross MH, Playe DW: Effects of activated polymorphonuclear leukocytes on vascular smooth muscle tone. Am J Physiol 1991;261:H327-H334.
31. Bertuglia S, Marchiafava PL, Colan-tuoni A: Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation. Car-diovasc Res 1996;31:947-952.
32. Sewerynek E, Reiter RJ, Melchiorri D, Ortiz GG, Lewinski A: Oxidative damage in the liver induced by ischemia-reperfusion: Protection by melatonin. Hepatogastroenterology 1996;43:898-905.
33. Pentney PT, Bubenik GA: Melatonin reduces the severity of dextran-induced colitis in mice. J Pineal Res 1995;19:31-39.
34. Giusti P, Lipartiti M, Franceschini D, Schiavo N, Floreani M, Manev H: Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. FASEB J 1996;10:891-896.
35. Maestroni GJM: Melatonin as a therapeutical agent in experimental endotoxic shock. J Pineal Res 1996; 20:84-89.
36. Nava F, Calapai G, Facciola G, Cuzzocrea S, Giuliani G, De Sarro A, Caputi AP: Melatonin effects on inhibition of thirst and fever induced by lipopolysaccharide in rat. Eur J Pharmacol 1997;331:267-274.
37. Cuzzocrea S, Zingarelli B, Costanti-no G, Szabo A, Salzman AL, Caputi AP, Szabo C: Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br J Pharmacol 1997;121:1065-1074.